Barely Significant
← all excerpts

Teriflunomide treatment reduces B cells in patients with MS.

Neurol Neuroimmunol Neuroinflamm · 2017 · PMC5656406 · PMID 29082295

1
hedged sentence
closest p
boldest claim

The sentences

a slight trendno p-value reported
A slight trend to reduced numbers was seen in Teff ( figure 2A ) and Treg ( figure 2B upper panel) cells after 12 months of treatment, whereas the percentage of Teff and Treg cells did not change ( figure 2C and figure 2B , lower panel).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.